PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 105 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $234,000 | -25.2% | 102,674 | +18.8% | 0.00% | – |
| Q4 2019 | $313,000 | -4.3% | 86,421 | -9.7% | 0.00% | – |
| Q3 2019 | $327,000 | -18.2% | 95,737 | +12.6% | 0.00% | – |
| Q2 2019 | $400,000 | +63.3% | 85,059 | +16.2% | 0.00% | – |
| Q1 2019 | $245,000 | +31.0% | 73,207 | +3.8% | 0.00% | – |
| Q4 2018 | $187,000 | -48.6% | 70,498 | +8.4% | 0.00% | – |
| Q3 2018 | $364,000 | – | 65,011 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,360,000 | $6,895,000 | 5.06% |
| Omega Fund Management, LLC | 778,230 | $3,946,000 | 2.91% |
| BVF INC/IL | 5,346,838 | $27,108,000 | 2.65% |
| Virtus ETF Advisers LLC | 152,550 | $773,000 | 0.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 842,632 | $4,272,000 | 0.59% |
| Tekla Capital Management LLC | 2,087,380 | $10,583,000 | 0.40% |
| Schonfeld Strategic Advisors LLC | 828,600 | $4,201,000 | 0.23% |
| Orbimed Advisors | 3,140,000 | $15,920,000 | 0.19% |
| Lombard Odier Asset Management (USA) Corp | 563,878 | $2,859,000 | 0.19% |
| Rhenman & Partners Asset Management AB | 300,000 | $1,521,000 | 0.16% |